| NCT ID | NCT02053376 |
| Title | A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of Pittsburgh |
| Indications | |
| Therapies | |
| Age Groups: | adult |